Cargando…

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

BACKGROUND: The effects of pharmacological blood-pressure-lowering on cardiovascular outcomes in individuals aged 70 years and older, particularly when blood pressure is not substantially increased, is uncertain. We compared the effects of blood-pressure-lowering treatment on the risk of major cardi...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473559/ https://www.ncbi.nlm.nih.gov/pubmed/34461040 http://dx.doi.org/10.1016/S0140-6736(21)01921-8

Ejemplares similares

Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review
por: Ho, Chau Le Bao, et al.
Publicado: (2017)

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Publicado: (2021)

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
por: Rahimi, Kazem, et al.
Publicado: (2019)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
por: Karmali, Kunal N., et al.
Publicado: (2018)

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis
por: Pinho-Gomes, Ana-Catarina, et al.
Publicado: (2021)

Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs
por: Satoh, Michihiro, et al.
Publicado: (2020)

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2022)

Distinctive prognostic factor of heart failure with preserved ejection fraction stratified with admission blood pressure
por: Nakagawa, Akito, et al.
Publicado: (2021)

Residual Cardiovascular Risk in Individuals on Blood Pressure–Lowering Treatment
por: Lieb, Wolfgang, et al.
Publicado: (2015)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements
por: McEvoy, John W., et al.
Publicado: (2021)

Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
por: Nghiem, Nhung, et al.
Publicado: (2019)

Age-stratified comparative analysis of the differences of gut microbiota associated with blood glucose level
por: Enqi, Wu, et al.
Publicado: (2019)

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis
por: Nazarzadeh, Milad, et al.
Publicado: (2021)

Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023)

Stratifying the stratifiers of triple negative breast cancer
por: Wang, Dong-Yu, et al.
Publicado: (2020)

Systolic blood pressure values might further risk-stratify the adverse outcomes of LVH in older patients with chronic kidney disease
por: Franco Palacios, Carlos R., et al.
Publicado: (2016)

Prediction of Lifetime Risk of Cardiovascular Disease Deaths Stratified by Sex in the Japanese Population
por: Imai, Yukiko, et al.
Publicado: (2021)

Serum Magnesium Levels and Cardiovascular Outcomes in Systolic Blood Pressure Intervention Trial Participants
por: Ferrè, Silvia, et al.
Publicado: (2023)

Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration
por: Clark, Christopher E., et al.
Publicado: (2022)

Risk Stratification by Self-Measured Home Blood Pressure across Categories of Conventional Blood Pressure: A Participant-Level Meta-Analysis
por: Asayama, Kei, et al.
Publicado: (2014)

Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels
por: Karmali, Kunal N, et al.
Publicado: (2015)

Blood pressure lowering in pregnancy
por: Sobieraj, Piotr
Publicado: (2021)

Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid-lowering component of ALLHAT
por: Rahman, Mahboob, et al.
Publicado: (2013)

Stratified polyhedra
por: Stone, David A
Publicado: (1972)

Stratified flows
por: Yih, Chia-Shun
Publicado: (1980)

Indications for tonsillectomy stratified by the level of evidence
por: Windfuhr, Jochen P.
Publicado: (2016)

Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
por: Paige, Ellie, et al.
Publicado: (2017)

Effects of isometric resistance training on resting blood pressure: individual participant data meta-analysis
por: Smart, Neil A., et al.
Publicado: (2019)

Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
por: Leening, Maarten J. G., et al.
Publicado: (2018)

How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?
por: Canoy, Dexter, et al.
Publicado: (2022)

Association between Vegetable Consumption and Blood Pressure, Stratified by BMI, among Chinese Adolescents Aged 13–17 Years: A National Cross-Sectional Study
por: Yang, Yide, et al.
Publicado: (2018)

Association of Blood Pressure With Stroke Risk, Stratified by Age and Stroke Type, in a Low-Income Population in China: A 27-Year Prospective Cohort Study
por: Du, Xin, et al.
Publicado: (2019)

Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control
por: Hardy, Shakia T., et al.
Publicado: (2015)

Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
por: Wang, Ji-Guang, et al.
Publicado: (2014)

Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018)

Methods and Consequences of Lowering the Blood Pressure
por: Paton, W. D. M.
Publicado: (1957)

Blood pressure lowering and potassium intake
por: Palmer, Biff F., et al.
Publicado: (2020)

Blood pressure in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data
por: Noten, Suzie, et al.
Publicado: (2021)

Can laboratory blood tests be used to risk stratify patients admitted with pneumonia?
por: Apps, L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_39rchenjknrras4pr9hcs4402h